Delivery Order SPE2DR25D1106-SPE2DR26FJA4D
Award Date 11/20/25
Potential Completion Date 11/21/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,001.25 to AmerisourceBergen Drug Corp for the supply of XCOPRI 50 MG tablets (30-count units) on October 30, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,768.44 delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count supply) under a firm fixed price contract type. The award was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of XCOPRI 200 mg tablets (30-count units) valued at $2,127.24. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of July 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $2,357.92 delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count units) under a firm fixed price contract. The order was competitively awarded without set-aside provisions and is scheduled for completion by September 18, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $3,536.88 delivery order to AmerisourceBergen Drug Corp for XCOPRI 25 mg tablets (30-count units) with a firm fixed price structure. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by June 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.00 to AmerisourceBergen Drug Corp for XCOPRI 100 MG tablets (30-count packaging) on November 14, 2025, with an ultimate completion date of November 17, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,319.99 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-unit supply) with a firm fixed price arrangement. This non-set-aside contract was competitively awarded on November 14, 2025, with an ultimate completion date of November 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,811.64 delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-unit supply) on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical product will be delivered to the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,646.82 delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of XCOPRI 100 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by May 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on September 16, 2025, with a ceiling value of $3,696.59 and ultimate completion date of September 17, 2025. The contract, issued under a firm fixed-price structure with no set-aside designation, calls for the delivery of XCOPRI 100 mg tablets (30-count units) to be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract...